logo-loader
AIM:IMM

ImmuPharma PLC

Receive alerts
Market:
AIM
Price
2.52 GBX
Day Change
-1.56%
Market Cap:
£15.76 m
52 weeks high
11.00
52 weeks low
2.41

In brief

ImmuPharma PLC is a biopharmaceutical company that specializes in the usage and development of biopolymers, specifically peptides.

The company is dedicated to developing an innovative portfolio of peptide-based therapeutic drugs with a focus on autoimmunity/inflammation and anti-infectives.

Snapshot

  • ImmuPharma eyes P140 licensing deal as scientific evidence mounts
  • Moderna, Legend Biotech advanced to the major league from the minors. But how do you spot a rookie company ready to move to the ‘show’?
  • Incathera shares up 70% on Marionnaud; ImmuPharma jumps 25%
  • ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developments